Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7528704rdf:typepubmed:Citationlld:pubmed
pubmed-article:7528704lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7528704lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:7528704lifeskim:mentionsumls-concept:C0002199lld:lifeskim
pubmed-article:7528704lifeskim:mentionsumls-concept:C0543697lld:lifeskim
pubmed-article:7528704lifeskim:mentionsumls-concept:C0023983lld:lifeskim
pubmed-article:7528704pubmed:issue4lld:pubmed
pubmed-article:7528704pubmed:dateCreated1995-1-30lld:pubmed
pubmed-article:7528704pubmed:abstractTextSeveral reports showed that mixed cryoglobulinemia (MC) is closely associated with hepatitis C virus (HCV) infection. Since several authors reported the efficacy of alpha-interferon in the treatment of MC, we investigated the long-term effects of this drug on clinical, hematological and virological parameters in a group of 18 patients (13 women and 5 men, mean age 56 +/- 11 years) affected by MC.lld:pubmed
pubmed-article:7528704pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7528704pubmed:languageenglld:pubmed
pubmed-article:7528704pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7528704pubmed:citationSubsetIMlld:pubmed
pubmed-article:7528704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7528704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7528704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7528704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7528704pubmed:statusMEDLINElld:pubmed
pubmed-article:7528704pubmed:issn0390-6078lld:pubmed
pubmed-article:7528704pubmed:authorpubmed-author:MorettiMMlld:pubmed
pubmed-article:7528704pubmed:authorpubmed-author:SantiniGGlld:pubmed
pubmed-article:7528704pubmed:authorpubmed-author:PozzatoGGlld:pubmed
pubmed-article:7528704pubmed:authorpubmed-author:CrovattoMMlld:pubmed
pubmed-article:7528704pubmed:authorpubmed-author:MazziGGlld:pubmed
pubmed-article:7528704pubmed:authorpubmed-author:MazzariMMlld:pubmed
pubmed-article:7528704pubmed:authorpubmed-author:ModoloM LMLlld:pubmed
pubmed-article:7528704pubmed:issnTypePrintlld:pubmed
pubmed-article:7528704pubmed:volume79lld:pubmed
pubmed-article:7528704pubmed:ownerNLMlld:pubmed
pubmed-article:7528704pubmed:authorsCompleteYlld:pubmed
pubmed-article:7528704pubmed:pagination342-9lld:pubmed
pubmed-article:7528704pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:meshHeadingpubmed-meshheading:7528704-...lld:pubmed
pubmed-article:7528704pubmed:articleTitleLong-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia.lld:pubmed
pubmed-article:7528704pubmed:affiliationDepartment of Medicine, Pordenone General Hospital, Italy.lld:pubmed
pubmed-article:7528704pubmed:publicationTypeJournal Articlelld:pubmed